FDA Inspection
Sarepta Therapeutics, Inc.Sarepta Therapeutics, Inc. – FDA Inspection, Apr 12, 2018
Record Details
This FDA Inspection record concerns Sarepta Therapeutics, Inc., with an inspection on April 12, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f4d7c881-87b3-4792-91f5-b556fe3f0046
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048077
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(c)(2)(ii)(B)Periodic safety report missing ICSR
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sarepta Therapeutics, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 18, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sarepta Therapeutics, Inc.
- FDA Inspection 1159812 - 2021-12-06
- FDA Inspection 1091489 - 2019-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.